KR20190130786A - The toothpaste composition - Google Patents
The toothpaste composition Download PDFInfo
- Publication number
- KR20190130786A KR20190130786A KR1020180055335A KR20180055335A KR20190130786A KR 20190130786 A KR20190130786 A KR 20190130786A KR 1020180055335 A KR1020180055335 A KR 1020180055335A KR 20180055335 A KR20180055335 A KR 20180055335A KR 20190130786 A KR20190130786 A KR 20190130786A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- pegmatite
- silicon dioxide
- extracts
- type silica
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 치약 조성물에 관한 것으로서, 보다 상세하게는 주성분으로서 이산화규소, 덴탈타입실리카, D-소르비톨액, 농글리세린, 코코일글루타민산나트륨 및 페그마타이트 등이 포함되어 구취 제거, 항균작용 및 치태 억제 효과가 우수한 치약 조성물에 관한 것이다.The present invention relates to a toothpaste composition, and more specifically, the main components include silicon dioxide, dental type silica, D-sorbitol liquid, concentrated glycerin, sodium cocoyl glutamate and pegmatite to remove bad breath, antibacterial action and plaque It relates to an excellent toothpaste composition.
본 발명의 기술이 속하는 치약은 치아를 청결하게 하고 연마할 목적으로 칫솔에 묻혀 사용하는 약물성 복합물질이다. 형태는 분말, 크림 또는 액상 등으로 이루어지고, 소독작용, 치석용해작용, 냄새감퇴작용 및 충치나 치조농루 등의 예방 또는 치료에 도움을 줄 수 있도록 만들어진다.Toothpaste to which the technology of the present invention belongs is a drug complex that is used by buried in a toothbrush for the purpose of cleaning and polishing teeth. The form is made of powder, cream or liquid, etc., and is made to assist in the prevention or treatment of disinfection, calculus dissolution, deodorization and tooth decay or alveolar rash.
종래에 주로 사용되는 기제에는 탄산칼슘, 인산칼슘, 황산칼슘, 탄산마그네슘, 염화마그네슘 등이 사용되고, 주로 치아의 기계적 청소에 효과적으로 작용하도록 사용되며, 입자의 크기와 경도 및 모양이 적당하지 않으면 치아의 표면을 손상시킬 우려가 있으므로, 입자의 크기는 대략 1~20㎛로서 균일하게 만들고, 결정은 치아가 상하지 않도록 예민하지 않게 만들며, 경도는 모스 굳기 3도 정도로 만든다.Conventionally used bases are calcium carbonate, calcium phosphate, calcium sulfate, magnesium carbonate, magnesium chloride, and the like, and are mainly used to effectively effect the mechanical cleaning of teeth, and if the size, hardness and shape of the particles are not appropriate, Because of the possibility of damaging the surface, the particle size is approximately 1-20 μm, uniformity, crystals are not sensitive to damage the teeth, and the hardness is about 3 degrees Mohs hardening.
상기와 같은 기제 외에 청정제, 향료, 색소, 살균소독제, 치석용해제, 중화제 등이 조금씩 혼입되어 있으며, 크림 타입에는 이외에도 접합제, 안정제 등이 첨가되고 있다.In addition to the bases described above, detergents, perfumes, colorants, disinfectant disinfectants, tartar dissolving agents, neutralizing agents, and the like are mixed little by little. In addition to the cream type, binders, stabilizers, and the like are added.
대한민국 등록특허 제314789호는 충치 예방 및 구강내 염증에 억제효과를 나타내는 치약 조성물에 있어서, 스핀고리피드를 활성성분으로 함유하는 충치 예방 및 구강내 염증 치료용 치약 조성물이 게재되어 있고, 대한민국 등록특허 제482648호는 옥 파우더 0.01~10중량% 및 두송나무 열매 추출물 0.001~10중량%가 함유된 치약조성물이 게재되어 있으며, 대한민국 공개특허 제2001-20067호에는 습윤제, 연마제, 점도조절제, 기포제 등으로 구성되는 치약 조성물에 있어서, 향치료법에 사용되는 천연의 에센셜 오일류를 그 종류에 따라 0.3~2.5중량% 만큼 α타입, β타입, γ타입의 싸이클로덱스트린의 혼합체 3.0~25.0중량%에 포접시켜 아로마테라피용 에센셜 오일을 함유하는 치약 조성물 및 그의 제조방법이 게재되어 있다.Republic of Korea Patent No. 314789 discloses a toothpaste composition exhibiting an inhibitory effect on caries prevention and intraoral inflammation, the toothpaste composition for preventing tooth decay and oral inflammation containing spinolipide as an active ingredient, and the Republic of Korea Patent Registration No. 482648 discloses a toothpaste composition containing 0.01 to 10% by weight of jade powder and 0.001 to 10% by weight of birch fruit extract, and Korean Patent Laid-Open No. 2001-20067 as a wetting agent, abrasive, viscosity regulator, foaming agent, etc. In the dentifrice composition, the essential oils used in the fragrance therapy are included in the mixture 3.0 ~ 25.0% by weight of the cyclodextrin mixture of α type, β type and γ type by 0.3 to 2.5% by weight depending on the type of aromatherapy. Toothpaste compositions containing the essential oils for use and methods for producing the same are disclosed.
그러나, 종래기술에서는 페그마타이트(Pegmatite)를 함유하는 치약 조성물에 대해서는 게재된 바 없다.However, there is no disclosure in the prior art about toothpaste compositions containing Pegmatite.
따라서, 본 발명은 구취 제거, 항균작용 및 치태 억제 효과를 우수하게 발현시키고자 주성분으로서 페그마타이트를 포함하여 이산화규소, 덴탈타입실리카, D-소르비톨액, 농글리세린 및 코코일글루타민산나트륨이 포함된 치약 조성물을 제공하고자 한다.Therefore, the present invention is a toothpaste composition containing silicon dioxide, dental type silica, D-sorbitol liquid, concentrated glycerin and sodium cocoyl glutamate, including pegmatite as the main component to express the bad breath removal, antibacterial action and plaque suppression effect To provide.
본 발명에 따른 치약 조성물의 구체적인 성분은, 치약 조성물의 총중량에 대하여 페그마타이트 1.50~2.50중량%, 이산화규소 1.50~8.50중량%, 덴탈타입실리카 10.42~17.60중량%, 알란토인클로로히드록시알루미늄 0.04~0.06중량%, 아미노카프로산 0.02~0.06중량%, D-소르비톨액 26.00~70.00중량%, 농글리세린 4.00~6.00중량%, 폴리에틸렌글리콜1500 0.60~1.40중량%, 카르복시메틸셀룰로오스나트륨 0.60~1.40중량%, 마트리카리아엑스 0.06~0.14중량%, 세이지엑스 0.06~0.14중량%, 유칼립투스추출물 0.06~0.14중량%, 알로에엑스 0.06~0.14중량%, 자몽종자추출물 0.12~0.28중량%, 자일리톨 0.06~0.14중량%, 효소처리스테비아 0.04~0.06중량%, L-멘톨 0.30~0.60중량%, 민트향 0.10~0.30중량%, 마이카 0.20~0.60중량%, 은박 0.006~0.014중량%, 코코일글루타민산나트륨 1.00~3.00중량% 및 정제수 8.58~31.60중량%가 포함되고, 상기 이산화규소의 입자 크기는 6~22μm이며, 상기 덴탈타입실리카 및 페그마타이트의 입자 크기는 각각 1~20μm이다.Specific components of the dentifrice composition according to the present invention, pegmatite 1.50 to 2.50% by weight, silicon dioxide 1.50 to 8.50% by weight, dental type silica 10.42 to 17.60% by weight, allantoin chlorohydroxyaluminum 0.04-0.06% by weight %, Aminocaproic acid 0.02-0.06 weight%, D-sorbitol solution 26.00-70.00 weight%, concentrated glycerin 4.00-6.00 weight%, polyethylene glycol 1500 0.60-1.40 weight%, carboxymethylcellulose sodium 0.60-1.40 weight%, Matrika 0.06 to 0.14% by weight of liax, 0.06 to 0.14% by weight of sage, 0.06 to 0.14% by weight of eucalyptus extract, 0.06 to 0.14% by weight of aloe extract, 0.12 to 0.28% by weight of grapefruit seed extract, 0.06 to 0.14% by weight of xylitol, enzyme treatment Stevia 0.04-0.06 weight%, L-menthol 0.30-0.60 weight%, Mint flavor 0.10-0.30 weight%, Mica 0.20-0.60 weight%, Silver foil 0.006-0.014 weight%, Cocoyl glutamate 1.00-3.00 weight% and Purified water 8.58 31.60 wt%, and the dioxide The bovine particle size is 6 ~ 22μm, the particle size of the dental type silica and pegmatite are each 1 ~ 20μm.
본 발명에 따른 치약 조성물을 사용하게 되면, 치태 제거 및 치석의 침착 방지 효과가 우수하고, 구취 제거 및 항균작용이 탁월하여 치아와 잇몸을 건강하게 유지하는데 유용한 효과가 발생된다.When the toothpaste composition according to the present invention is used, it is excellent in removing plaque and preventing deposition of tartar, and it is excellent in removing bad breath and antibacterial effect, thereby generating a useful effect in maintaining teeth and gums.
본 발명에 따른 치약 조성물에는 페그마타이트, 이산화규소, 덴탈타입실리카, 알란토인클로로히드록시알루미늄, 아미노카프로산, D-소르비톨액, 농글리세린, 폴리에틸렌글리콜1500, 카르복시메틸셀룰로오스나트륨, 마트리카리아엑스, 세이지엑스, 유칼립투스추출물, 알로에엑스, 자몽종자추출물, 자일리톨, 효소처리스테비아, L-멘톨, 민트향, 마이카, 은박, 코코일글루타민산나트륨 및 정제수가 일정한 비율로 포함된다.Toothpaste compositions according to the present invention include pegmatite, silicon dioxide, dental type silica, allantoin chlorohydroxyaluminum, aminocaproic acid, D-sorbitol solution, concentrated glycerin, polyethylene glycol 1500, carboxymethyl cellulose sodium, matricariax, sage extract , Eucalyptus extract, aloe extract, grapefruit seed extract, xylitol, enzyme treatment stevia, L-menthol, mint flavor, mica, silver foil, sodium cocoyl glutamate and purified water are included in certain proportions.
상기 페그마타이트는 치태 제거, 구취 제거 및 항균성을 향상시킨다. 페그마타이트는 상온에서 원적외선을 다량 방출하고 탈취효과와 항균효과를 나타내는 천연석으로서, 페그마타이트(Pegmatite)의 분말을 치약 조성물에 함유시킴으로써, 구강내 독소와 염증제거 및 통증완화의 약리작용에 활용할 수 있으나, 지금까지 치약에 사용되고 있지 않는 실정이다.The pegmatite improves plaque removal, bad breath removal and antibacterial properties. Pegmatite is a natural stone that emits large amounts of far-infrared rays at room temperature and exhibits deodorizing and antibacterial effects. It can be used for pharmacological action of oral toxins, inflammation and pain relief by incorporating Pegmatite powder in toothpaste compositions. Until now is not used in toothpaste.
종래 공지된 연마제로는 탄산칼슘, 인산칼슘, 이산화규소, 인산칼슘, 무수규산, 수산화알루미늄 등이 있으나, 본 발명은 연마제로서 페그마타이트, 이산화규소, 덴탈타입실리카의 조합을 사용하는 것이 특징이다.Conventionally known abrasives include calcium carbonate, calcium phosphate, silicon dioxide, calcium phosphate, silicic anhydride, aluminum hydroxide, and the like, but the present invention is characterized by using a combination of pegmatite, silicon dioxide, and dental type silica as an abrasive.
본 발명에서 연마제로 사용되는 페그마타이트, 이산화규소, 덴탈타입실리카는 치아에 부착된 치구, 치석 등을 제거하여 치아 표면에 본연의 광택을 주는 작용을 한다. 연마력은 연마제의 종류, 배합량, 연마제의 입자 크기에 따라 결정되고, 통상 20μm까지는 입자가 커짐에 따라 연마력도 함께 높아진다.Pegmatite, silicon dioxide, and dental type silica used as an abrasive in the present invention remove the jig, calculus, etc. attached to the tooth, thereby giving a natural luster to the surface of the tooth. The polishing force is determined according to the type of abrasive, the compounding amount, and the particle size of the abrasive. Usually, as the particles grow up to 20 μm, the polishing force also increases.
또한, 연마제는 백색의 무미, 무취의 분말상으로서, 치아의 상태를 손상시키지 않을 정도의 경도를 유지해야 하고, 입자의 결정은 침상이나 봉상 등 치아의 손상을 유발하는 형상은 회피해야 하며, 입자의 지름은 1~20μm로 작아야 하고, pH는 약산성 중성 또는 약알칼리성인 것이 바람직하다.In addition, the abrasive is white, tasteless and odorless powder, and should maintain a hardness that does not damage the state of the teeth, and the crystal grains should avoid shapes that cause tooth damage such as needles and rods. The diameter should be as small as 1-20 μm, and the pH is preferably weakly acidic neutral or weakly alkaline.
한편, 상기 이산화규소는 바람직한 연마 효과를 갖기 위해 6~22μm의 크기인 것이 바람직하고, 상기 덴탈타입실리카는 자극 없이 치태의 침착을 예방시켜주고 치아를 건강하고 하얗게 하는 효과가 있다.On the other hand, the silicon dioxide is preferably in the size of 6 ~ 22μm in order to have a desirable polishing effect, the dental type silica has the effect of preventing the deposition of plaque without irritation and healthy and white teeth.
또한, 본 발명의 조성물에서 아미노카프로산 및 알란토인클로로히드록시알루미늄은 치주질환 예방제로서 사용되되, 아미노카프로산은 항출혈 항염증 효능이 우수하여 지혈 작용을 통해 잇몸의 출혈을 예방하고, 알란토인클로로히드록시알루미늄은 구강점막을 보호하여 잇몸염증 방지, 치은염 및 치주염에 수반되는 부기 및 발적을 예방하며 잇몸 염증과 통증을 경감해 주는 효과가 있다.In addition, aminocaproic acid and allantoin chlorohydroxyaluminum in the composition of the present invention is used as a preventive of periodontal disease, aminocaproic acid is excellent anti-bleeding anti-inflammatory effect to prevent bleeding of the gums through hemostatic action, allantoinchlorohydroxy Aluminum protects the oral mucosa and prevents gum inflammation, prevents swelling and redness associated with gingivitis and periodontitis, and reduces gum inflammation and pain.
이하, 본 발명의 목적을 달성할 수 있는 치약 조성물의 구체적인 조성물과 그에 따른 성분비를 설명하면 다음과 같다.Hereinafter, the specific composition of the dentifrice composition which can achieve the objective of this invention and its component ratio are as follows.
치약 조성물의 총중량에 대하여 페그마타이트 1.50~2.50중량%, 이산화규소 1.50~8.50중량%, 덴탈타입실리카 10.42~17.60중량%, 알란토인클로로히드록시알루미늄 0.04~0.06중량%, 아미노카프로산 0.02~0.06중량%, D-소르비톨액 26.00~70.00중량%, 농글리세린 4.00~6.00중량%, 폴리에틸렌글리콜1500 0.60~1.40중량%, 카르복시메틸셀룰로오스나트륨 0.60~1.40중량%, 마트리카리아엑스 0.06~0.14중량%, 세이지엑스 0.06~0.14중량%, 유칼립투스추출물 0.06~0.14중량%, 알로에엑스 0.06~0.14중량%, 자몽종자추출물 0.12~0.28중량%, 자일리톨 0.06~0.14중량%, 효소처리스테비아 0.04~0.06중량%, L-멘톨 0.30~0.60중량%, 민트향 0.10~0.30중량%, 마이카 0.20~0.60중량%, 은박 0.006~0.014중량%, 코코일글루타민산나트륨 1.00~3.00중량% 및 정제수 8.58~31.60중량%가 일정한 비율로 포함된다.Pegmatite 1.50 ~ 2.50% by weight, silicon dioxide 1.50 ~ 8.50% by weight, dental type silica 10.42 ~ 17.60% by weight, allantoin chlorohydroxyaluminum 0.04-0.06% by weight, aminocaproic acid 0.02 ~ 0.06% by weight, D-sorbitol solution 26.00 ~ 70.00% by weight, concentrated glycerin 4.00 ~ 6.00%, polyethylene glycol 1500 0.60 ~ 1.40% by weight, carboxymethylcellulose sodium 0.60 ~ 1.40% by weight, matricariax 0.06 ~ 0.14% by weight, SageX 0.06 ~ 0.14 wt%, Eucalyptus extract 0.06 ~ 0.14 wt%, Aloe X 0.06 ~ 0.14 wt%, Grapefruit seed extract 0.12 ~ 0.28 wt%, Xylitol 0.06 ~ 0.14 wt%, Enzyme-treated stevia 0.04-0.06 wt%, L-menthol 0.30 ~ 0.60 wt%, mint flavor 0.10 ~ 0.30 wt%, mica 0.20 ~ 0.60 wt%, silver foil 0.006 ~ 0.014 wt%, sodium cocoyl glutamate sodium 1.00 ~ 3.00 wt% and purified water 8.58 ~ 31.60 wt% are included in a constant ratio.
상기한 조성물들의 구체적인 성분비가 포함된 실시예는 다음과 같다.Examples in which specific component ratios of the above-described compositions are included are as follows.
치약 조성물의 총중량 750.00g에 대하여 페그마타이트 1.50~2.50중량%에 해당하는 11.25~18.75g과, 이산화규소 1.50~8.50중량%에 해당하는 11.25~63.75g과, 덴탈타입실리카 10.42~17.60중량%에 해당하는 78.15~132.00g과, 알란토인클로로히드록시알루미늄 0.04~0.06중량%에 해당하는 0.30~0.45g과, 아미노카프로산 0.02~0.06중량%에 해당하는 0.15~0.45g과, D-소르비톨액 26.00~70.00중량%에 해당하는 195.00~525.00g과, 농글리세린 4.00~6.00중량%에 해당하는 30.00~45.00g과, 폴리에틸렌글리콜1500 0.60~1.40중량%에 해당하는 4.50~10.50g과, 카르복시메틸셀룰로오스나트륨 0.60~1.40중량%에 해당하는 4.50~10.50g과, 마트리카리아엑스 0.06~0.14중량%에 해당하는 0.45~1.05g과, 세이지엑스 0.06~0.14중량%에 해당하는 0.45~1.05g과, 유칼립투스추출물 0.06~0.14중량%에 해당하는 0.45~1.05g과, 알로에엑스 0.06~0.14중량%에 해당하는 0.45~1.05g과, 자몽종자추출물 0.12~0.28중량%에 해당하는 0.90~2.10g과, 자일리톨 0.06~0.14중량%에 해당하는 0.45~1.05g과, 효소처리스테비아 0.04~0.06중량%에 해당하는 0.30~0.45g과, L-멘톨 0.30~0.60중량%에 해당하는 2.25~4.50g과, 민트향 0.10~0.30중량%에 해당하는 0.75~2.25g과, 마이카 0.20~0.60중량%에 해당하는 1.50~4.50g과, 은박 0.006~0.014중량%에 해당하는 0.05~0.11g과, 코코일글루타민산나트륨 1.00~3.00중량%에 해당하는 7.50~22.50g과 및 정제수 8.58~31.60중량%에 해당하는 64.35~237.00g을 포함시켜 진공상태에서 20분간 교반시키면서 점성이 있는 페이스트 상태로 본 발명의 치약 조성물이 제조된다.11.25 to 18.75 g corresponding to 1.50 to 2.50 weight% pegmatite, 11.25 to 63.75 g corresponding to 1.50 to 8.50 weight% of silicon dioxide, and 10.42 to 17.60 weight% of dental type silica, relative to the total weight of 750.00 g of the toothpaste composition. 78.15 to 132.00 g, 0.30 to 0.45 g corresponding to 0.04 to 0.06 weight% of allantoinchlorohydroxyaluminum, 0.15 to 0.45 g corresponding to 0.02 to 0.06 weight% of aminocaproic acid, and 26.00 to 70.00 weight of D-sorbitol solution 195.00 to 525.00 g corresponding to%, 30.00 to 45.00 g corresponding to 4.00 to 6.00 weight% of concentrated glycerin, 4.50 to 10.50 g corresponding to 0.60 to 1.40 weight% of polyethylene glycol 1500, and 0.60 to 1.40 sodium carboxymethylcellulose 4.50 ~ 10.50g corresponding to weight%, 0.45 ~ 1.05g corresponding to 0.06 ~ 0.14% by weight of Matricariax, 0.45 ~ 1.05g corresponding to 0.06 ~ 0.14% by weight of SageX, and 0.06 ~ 0.14 Eucalyptus extract 0.45 ~ 1.05g corresponding to weight% and 0.45 ~ 1.0 corresponding to 0.06 ~ 0.14% by weight of Aloe X 5 g, 0.90 to 2.10 g corresponding to 0.12 to 0.28 wt% of grapefruit seed extract, 0.45 to 1.05 g corresponding to 0.06 to 0.14 wt% of xylitol, and 0.30 to 0.45 g corresponding to 0.04 to 0.06 wt% of enzyme-treated stevia And 2.25 to 4.50 g corresponding to 0.30 to 0.60% by weight of L-menthol, 0.75 to 2.25 g corresponding to 0.10 to 0.30% by weight of mint, 1.50 to 4.50 g corresponding to 0.20 to 0.60% by weight of mica, Vacuum containing 0.05 to 0.11 g corresponding to 0.006 to 0.014 weight% of silver foil, 7.50 to 22.50 g corresponding to 1.00 to 3.00 weight% of sodium cocoyl glutamate, and 64.35 to 237.00 g corresponding to 8.58 to 31.60 weight% of purified water. The toothpaste composition of this invention is manufactured in a viscous paste state, stirring for 20 minutes in the state.
참고로, 상기와 같은 각각의 조성물에서 각각의 성분중 최저치의 수치로만 본 발명에 따른 치약 조성물을 만들면 치약 조성물의 총중량은 414.95g이 되고, 각각의 성분중 최고치의 수치로만 본 발명에 따른 치약 조성물을 만들면 치약 조성물의 총중량은 1,085.06g이 됨에 따라, 상기한 실시예처럼 본 발명에 따른 치약 조성물은 414.95~1,085.06g 사이에서 만들어지는 것이 바람직하다.For reference, when the toothpaste composition according to the present invention is made only at the lowest value of each component in each of the above compositions, the total weight of the toothpaste composition is 414.95 g, and the toothpaste composition according to the present invention is only at the highest value of each component. When making the total weight of the toothpaste composition is 1,085.06g, the toothpaste composition according to the present invention is preferably made between 414.95 ~ 1,085.06g as described above.
이러한 실시예는 하나의 예시일 뿐, 본 발명은 이에 한정되지 않으며, 치약 조성물의 총중량을 늘리면서 대량으로 생산할 때에는 각각의 성분비의 범위내에서 얼마든지 대량으로 치약 조성물을 만들 수 있다.This embodiment is only one example, the present invention is not limited thereto, and when producing a large amount while increasing the total weight of the toothpaste composition, it is possible to make the toothpaste composition in any amount within the range of each component ratio.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180055335A KR20190130786A (en) | 2018-05-15 | 2018-05-15 | The toothpaste composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180055335A KR20190130786A (en) | 2018-05-15 | 2018-05-15 | The toothpaste composition |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190130786A true KR20190130786A (en) | 2019-11-25 |
Family
ID=68730501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180055335A KR20190130786A (en) | 2018-05-15 | 2018-05-15 | The toothpaste composition |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190130786A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3690108A1 (en) | 2019-02-01 | 2020-08-05 | LG Electronics Inc. -1- | Laundry treating apparatus |
KR102267003B1 (en) * | 2021-03-31 | 2021-06-18 | 이조원 | Toothpaste composition containing melanterite |
-
2018
- 2018-05-15 KR KR1020180055335A patent/KR20190130786A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3690108A1 (en) | 2019-02-01 | 2020-08-05 | LG Electronics Inc. -1- | Laundry treating apparatus |
KR102267003B1 (en) * | 2021-03-31 | 2021-06-18 | 이조원 | Toothpaste composition containing melanterite |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080031831A1 (en) | Oral anti-calculus compositions and methods of use thereof | |
US3651208A (en) | Dentifrice for periodontia purposes | |
US11576947B2 (en) | Oral composition and method | |
AU2009212339B2 (en) | Tooth sealant | |
JP5867546B2 (en) | Dentifrice composition, oral anti-inflammatory agent and oral malodor | |
JP5493731B2 (en) | Dentifrice composition | |
JP2007210922A (en) | Oral composition | |
KR20190130786A (en) | The toothpaste composition | |
Bharkhavy et al. | Silver, the magic bullet in dentistry–A review | |
KR20080013445A (en) | Composition of toothpaste | |
KR20210069513A (en) | The toothpaste composition having oral bactericidal function | |
JP2021095380A (en) | Dentifrice composition | |
JP2013151473A (en) | Composition for oral cavity | |
Kashyap et al. | Irrigating solutions in pediatric dentistry: a big deal in little teeth | |
JP4656293B2 (en) | Oral composition | |
JP2016124855A (en) | Oral hydrogel composition | |
US11583481B2 (en) | Dentifrice formulations and methods of oral care | |
JP6884776B2 (en) | Composition | |
RU2286763C2 (en) | Dental paste | |
Stoleriu et al. | The use of arginine containing toothpastes in dental hard tissues remineralization | |
Kumar et al. | Advanced materials for prevention of calculus formation on enamel: A review | |
JP6349709B2 (en) | Oral composition | |
CN110691581B (en) | Dentifrice composition | |
JP7073402B2 (en) | Oral composition | |
KR102550067B1 (en) | Oral Composition having policresulen and fluorine compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal |